MLAB vs. SENS, VERV, PRME, ALLO, PROK, CVAC, MLYS, NUVB, NVAX, and GHRS
Should you be buying Mesa Laboratories stock or one of its competitors? The main competitors of Mesa Laboratories include Senseonics (SENS), Verve Therapeutics (VERV), Prime Medicine (PRME), Allogene Therapeutics (ALLO), ProKidney (PROK), CureVac (CVAC), Mineralys Therapeutics (MLYS), Nuvation Bio (NUVB), Novavax (NVAX), and GH Research (GHRS). These companies are all part of the "medical" sector.
Mesa Laboratories (NASDAQ:MLAB) and Senseonics (NYSE:SENS) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, media sentiment, institutional ownership, risk, community ranking and analyst recommendations.
Mesa Laboratories has higher revenue and earnings than Senseonics. Senseonics is trading at a lower price-to-earnings ratio than Mesa Laboratories, indicating that it is currently the more affordable of the two stocks.
90.6% of Mesa Laboratories shares are held by institutional investors. Comparatively, 12.4% of Senseonics shares are held by institutional investors. 5.2% of Mesa Laboratories shares are held by company insiders. Comparatively, 3.9% of Senseonics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Mesa Laboratories currently has a consensus target price of $130.00, suggesting a potential upside of 27.70%. Senseonics has a consensus target price of $1.25, suggesting a potential upside of 199.76%. Given Senseonics' higher possible upside, analysts plainly believe Senseonics is more favorable than Mesa Laboratories.
In the previous week, Mesa Laboratories and Mesa Laboratories both had 1 articles in the media. Mesa Laboratories' average media sentiment score of 1.02 beat Senseonics' score of 0.00 indicating that Mesa Laboratories is being referred to more favorably in the media.
Mesa Laboratories has a beta of 0.83, suggesting that its stock price is 17% less volatile than the S&P 500. Comparatively, Senseonics has a beta of 0.87, suggesting that its stock price is 13% less volatile than the S&P 500.
Mesa Laboratories received 216 more outperform votes than Senseonics when rated by MarketBeat users. Likewise, 63.82% of users gave Mesa Laboratories an outperform vote while only 25.00% of users gave Senseonics an outperform vote.
Mesa Laboratories has a net margin of 0.45% compared to Senseonics' net margin of -270.13%. Mesa Laboratories' return on equity of 7.41% beat Senseonics' return on equity.
Summary
Mesa Laboratories beats Senseonics on 13 of the 16 factors compared between the two stocks.
Get Mesa Laboratories News Delivered to You Automatically
Sign up to receive the latest news and ratings for MLAB and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MLAB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Mesa Laboratories Competitors List
Related Companies and Tools
